In the article by Hartmann et al, entitled “Treatment of Refractory Hodgkin's Disease With an Anti-CD16/CD30 Bispecific Antibody,” which appeared in the March 15, 1997 issue (Vol 89, No 6, pp 2024-2047), corrections should be noted. In the abstract section, right-hand column, line 4 should have read, “A total of 1 complete and 1 partial remission (lasting 6 and 3 months, respectively) …”, not “A total of 1 complete and 1 partial remission (lasting 16 and 3 months, respectively) …” as printed. In addition, on page 2044, in Table 2, the third entry in the second column should have read, “2 mg/m2 × 4”, not “2 mg/m2 × 2”, as printed.

Sign in via your Institution